Self-assembled benzoselenadiazole-capped tripeptide hydrogels with inherent in vitro anti-cancer and anti-inflammatory activity

Tapas Ghosh; Shu Wang; Dharmendra Kashyap; Rohit G Jadhav; Tanmay Rit; Hem Chandra Jha; Brian G Cousins; Apurba K Das

doi:10.1039/d2cc01160c

Self-assembled benzoselenadiazole-capped tripeptide hydrogels with inherent in vitro anti-cancer and anti-inflammatory activity

Chem Commun (Camb). 2022 Jul 5;58(54):7534-7537. doi: 10.1039/d2cc01160c.

Authors

Tapas Ghosh¹, Shu Wang², Dharmendra Kashyap³, Rohit G Jadhav¹, Tanmay Rit¹, Hem Chandra Jha³, Brian G Cousins², Apurba K Das¹

Affiliations

¹ Department of Chemistry, Indian Institute of Technology Indore, Indore 453552, India. apurba.das@iiti.ac.in.
² Department of Chemistry, Loughborough University, Loughborough LE11 3TU, UK.
³ Department of Biosciences and Biomedical Engineering, Indian Institute of Technology Indore, Indore 453552, India.

PMID: 35703336
DOI: 10.1039/d2cc01160c

Abstract

Self-assembled benzoselenadiazole (BSe)-capped tripeptide based nanofibrillar hydrogels have been developed with inherent anticancer and anti-inflammatory activity.

MeSH terms

Anti-Inflammatory Agents* / pharmacology
Hydrogels* / pharmacology

Substances

Anti-Inflammatory Agents
Hydrogels